Luneau Technology Launches as 'Visionix' to Manufacture and Sell Optovue, Visionix, Briot and Weco Brands
Luneau Technology Group recently announced that it will take on 'Visionix' as its official global name beginning March 31, 2022, unveiling a combined booth at Vision Expo East. As mentioned in the recent global announcement, 'Optovue' will transition to a product brand for Visionix’s OCT and OCTA line.
Headquartered in France, Visionix develops, manufactures, and markets ophthalmic equipment from refraction and multimodal diagnostic devices to lens finishing equipment. The Visionix brand comprises the formerly individual brands of Luneau Technology, Briot (finishing), Weco (finishing), Visionix (diagnosis and refraction), Next Sight (fundus camera and telehealth solutions), and Optovue (high-speed OCT and OCTA technology). The new Visionix company will be the global sales, service, and training provider for all product brands, integrating core refractive, screening, and imaging technologies to address the needs of eye care professionals.
The Visionix product line, the company’s flagship brand, was founded by CEO and President Marc Abitbol, PhD, in1994 as a research and development lab for applications in wavefront-based technology. Within the last three decades, the company has expanded its range of offerings with the addition of other specialty brands like Briot and Weco (acquired in 2010) and Optovue (merged in 2021). Today, the group has 700 employees in 120 countries, and offers a wide range of products.
“We have grown our business significantly over the past several years, and our new brand reflects that transformation,” Dr. Abitbol said in a company news release. “Our new identity is innovative, modern, and professional—words we use to describe who we are as an organization but also the technology solutions we provide to our customers who want to expand their business. Today, Visionix offers an integrated range of multimodal products primarily serving eye care professionals. Our ambition is to be a world-class leader and the first choice for helping providers simplify their patients’ access to visual health.”
North America: What is changing?
North America is a primary focus of the new group. There are fewer than 700,000 eye care professionals globally for a 7.2 billion population, resulting in delayed access to ophthalmic care. Automated and integrated Visionix technologies were designed to assist in closing this gap and to help practices grow and serve more patients.
As a result of the merger with Optovue, the North American organization tripled its team of field representatives for Sales, Service, and Clinical Application, introducing more specialized professionals to consult with ECPs throughout the buying process and beyond. Dan McNulty continues to lead the expanded team as President for its commercial organization in North America.
Visionix: New technology to help Practitioners detect a range of eye health symptoms
For the first time at Vision Expo East, Visionix will introduce a remote-ready refraction and screening technology suite integrating its most advanced multi-modal devices. The next-generation Visionix platforms offer varying levels of patient data integration, and the most advanced solutions offer multiple test functionalities in a single device—providing all necessary data for a comprehensive exam with significantly less patient movement from instrument to instrument.
The second-generation Eye Refract is a highly automated and dynamic binocular, wavefront-based refraction system that includes a digital acuity short chart and the VX40 lens analyzer.
The newest addition to its multi-modal screening line is VX650, which combines a 45-degree fundus camera with several technologies in one single device, including: Shack-Hartmann Wavefront based anterior segment analysis, with autorefraction/keratometry, placido ring corneal topography, anterior/posterior corneal tomography, aberrometry, retro-illumination, anterior chamber analysis, pachymetry, Scheimpflug imaging, and non-contact tonometry.
VX650 integrates seamlessly with the compact Eye Refract and can be placed on a single tabletop or set up separately in a five square feet pre-test room, offering a complete suite with a small footprint. The optional table’s ergonomic design even allows a wheelchair to fit comfortably, an excellent benefit for practitioners who see patients with mobility issues.
Optovue: An OCT and OCTA for every practice
The company will be unveiling its expanded product line at Vision Expo East, with a wide range of OCT technology alongside its screening, refraction, and optical brands. The Optovue line offers high-speed OCT and OCT-A technology to equip providers with the best imaging tools to diagnose and manage eye diseases. The company’s most advanced solution today is the Optovue Avanti Widefield OCT, which offers state-of- the-art imaging from the cornea to the choroid with exclusive technology that will change your approach to disease diagnosis and management.